Comparison of the Efficacy between Conventional Moxibustion and Smoke-Free Moxibustion on Knee Osteoarthritis: A Randomized Controlled Trial

Ling Luo, Mo Liao, Jia-Xi Peng, Qi Ma, Jian-Ying Zhou, Lin-Lin Zhu, Xiang Wang, Sha-Sha Chen, Hai-Yan Yin, Qiao-Feng Wu, Cheng-Shun Zhang, Peng Lv, Yong Tang, Shu-Guang Yu, Ling Luo, Mo Liao, Jia-Xi Peng, Qi Ma, Jian-Ying Zhou, Lin-Lin Zhu, Xiang Wang, Sha-Sha Chen, Hai-Yan Yin, Qiao-Feng Wu, Cheng-Shun Zhang, Peng Lv, Yong Tang, Shu-Guang Yu

Abstract

Objective: The aim of this study was to investigate the difference of efficacy between conventional moxibustion (CM) and smoke-free moxibustion (SM) for patients with osteoarthritis of the knee (KOA).

Methods: This is a multicentre, randomized, single blinded, parallel-group clinical trial. Patients with KOA were randomly allocated to CM group (69) and SM group (69) in 7 hospitals of China. Moxibustion treatment in 12 sessions over 4 weeks was administrated at 3 acupuncture points (EX-LE4, ST35, and ST36). Patients completed standard questionnaires at baseline and after 2 weeks, 4 weeks, 8 weeks, and 12 weeks. The primary outcome was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) from the baseline to 4 weeks. The secondary outcomes include Visual Analogue Scale (VAS) and Patient Global Assessment score (PGA).

Results: Analyses showed that the WOMAC score improved in pain (95% CI,-0.1[-1.2 to 0.9], p=0.76), stiffness (95% CI,-0.1 [-0.5 to 0.3], p=0.71), and function (95% CI, 2.2 [-1.3 to 5.8], p=0.22) compared between the two groups at 4 weeks, as well as the VAS score (95% CI,0.1 [-0.3 to 0.6], p=0.60). Similar results presented at 8 and 12 weeks. No statistically significant difference was observed between CM and SM groups for outcome measurements.

Conclusions: It suggested that smoke generated during moxibustion treatment does not affect the efficacy of moxibustion in the treatment of KOA, which should be taken into account to be removed for the sake of reducing environmental pollution or moxa smoke exposure of acupuncturists or patients. This trial is registered with Clinical Trials.gov, NCT02772055.

Figures

Figure 1
Figure 1
Flow of participants through the trial.

References

    1. Sharma L., Kapoor D., Issa S. Epidemiology of osteoarthritis: an update. Current Opinion in Rheumatology. 2006;18(2):147–156. doi: 10.1097/01.bor.0000209426.84775.f8.
    1. Dawson J., Linsell L., Zondervan K., et al. Impact of persistent hip or knee pain on overall health status in elderly people: a longitudinal population study. Arthritis Care & Research. 2005;53(3):368–374. doi: 10.1002/art.21180.
    1. Jinks C., Jordan K., Ong B. N., Croft P. A brief screening tool for knee pain in primary care (KNEST). 2. Results from a survey in the general population aged 50 and over. Rheumatology. 2004;43(1):55–61. doi: 10.1093/rheumatology/keg438.
    1. Hay E. M., Foster N. E., Thomas E., et al. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial. British Medical Journal. 2006;333(7576):995–998. doi: 10.1136/bmj.38977.590752.0B.
    1. Tramèr M. R., Moore R. A., Reynolds D. J. M., McQuay H. J. Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. PAIN. 2000;85(1-2):169–182. doi: 10.1016/s0304-3959(99)00267-5.
    1. Hunter D. J., Felson D. T. Osteoarthritis. British Medical Journal. 2006;332(7542):639–642. doi: 10.1136/bmj.332.7542.639.
    1. National Clinical Guideline Centre (UK) Osteoarthritis: Care and Management in Adults. London, UK: 2014.
    1. McAlindon T. E., Bannuru R. R., Sullivan M. C., et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage. 2014;22(3):363–388. doi: 10.1016/j.joca.2014.01.003.
    1. Zhang W., Nuki G., Moskowitz R. W., et al. OARSI recommendations for the management of hip and knee osteoarthritis. part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis and Cartilage. 2010;18(4):476–499. doi: 10.1016/j.joca.2010.01.013.
    1. Barnes P. M., Bloom B., Nahin R. L. Complementary and alternative medicine use among adults and children: united states, 2007. National Health Statistics Reports. 2009;10(12):1–23.
    1. Foster N. E., Thomas E., Barlas P., et al. Acupuncture as an adjunct to exercise based physiotherapy for osteoarthritis of the knee: randomised controlled trial. British Medical Journal. 2007;335(7617):436–440. doi: 10.1136/.
    1. Hinman R. S., McCrory P., Pirotta M., et al. Acupuncture for chronic knee pain a randomized clinical trial. Journal of the American Medical Association. 2014;312(13):1313–1322. doi: 10.1001/jama.2014.12660.
    1. Witt C., Brinkhaus B., Jena S., et al. Acupuncture in patients with osteoarthritis of the knee: a randomised trial. The Lancet. 2005;366(9480):136–143. doi: 10.1016/S0140-6736(05)66871-7.
    1. Cheng C., Fu S., Zhou Q., et al. Extending the CONSORT statement to moxibustion. Journal of Integrative Medicine. 2013;11(1):54–63. doi: 10.3736/jintegrmed2013009.
    1. Cho Z. H., Hwang S. C., Wong E. K., et al. Neural substrates, experimental evidences and functional hypothesis of acupuncture mechanisms. Acta Neurologica Scandinavica. 2006;113(6):370–377. doi: 10.1111/j.1600-0404.2006.00600.x.
    1. Zhang J. F., Wu Y. C., Shao M. H. Modern progress of mechanism of moxibustion therapy. Journal of Acupuncture and Tuina Science. 2006;4(5):257–260. doi: 10.1007/s11726-005-0257-1.
    1. Zhao L., Cheng K., Wang L., et al. Effectiveness of moxibustion treatment as adjunctive therapy in osteoarthritis of the knee: a randomized, double-blinded, placebo-controlled clinical trial. Arthritis Research & Therapy. 2014;16(3, article R133) doi: 10.1186/ar4590.
    1. Chen R., Chen M., Xiong J., et al. Comparative effectiveness of the deqi sensation and non-deqi by moxibustion stimulation: a multicenter prospective cohort study in the treatment of knee osteoarthritis. Evidence-Based Complementary and Alternative Medicine. 2013;2013:7. doi: 10.1155/2013/906947.906947
    1. Ren X., Yao C., Wu F., et al. Effectiveness of moxibustion treatment in quality of life in patients with knee osteoarthritis: a randomized, double-blinded, placebo-controlled trial. Evidence-Based Complementary and Alternative Medicine. 2015;2015:6. doi: 10.1155/2015/569523.569523
    1. Shen X., Lao L., Zhang Y., Cheng K. Biophysical and clinical research on acupuncture and moxibustion. Evidence-Based Complementary and Alternative Medicine. 2015;2015:2. doi: 10.1155/2015/518138.518138
    1. Li A., Wei Z., Liu Y., Li B., Guo X., Feng S. Moxibustion treatment for knee osteoarthritis. Medicine. 2016;95(14, article e3244) doi: 10.1097/MD.0000000000003244.
    1. Choi T.-Y., Kim T.-H., Kang J. W., Lee M. S., Ernst E. Moxibustion for rheumatic conditions: A systematic review and meta-analysis. Clinical Rheumatology. 2011;30(7):937–945. doi: 10.1007/s10067-011-1706-5.
    1. Zhu L., Zhou J., Luo L., et al. Comparison of the efficacy between conventional moxibustion and smoke-free moxibustion on knee osteoarthritis: study protocol of a randomized controlled trial. Trials. 2017;18(1):p. 188. doi: 10.1186/s13063-017-1846-2.
    1. Deng H., Shen X. The mechanism of moxibustion: ancient theory and modern research. Evidence-Based Complementary and Alternative Medicine. 2013;2013:7. doi: 10.1155/2013/379291.379291
    1. Hitosugi N., Ohno R., Hatsukari J., et al. Diverse biological activities of Moxa extract and smoke. In Vivo. 2001;15(3):249–254.
    1. Zhou C., Feng X., Wang J., et al. Research advance on moxa smoke. Journal of Acupuncture and Tuina Science. 2011;9(2):67–72. doi: 10.1007/s11726-011-0474-8.
    1. Matsumoto T., Katai S., Namiki T. Safety of smoke generated by Japanese moxa upon combustion. European Journal of Integrative Medicine. 2016;8(4):414–422. doi: 10.1016/j.eujim.2016.03.005.
    1. Zhang R. Accidents in acupuncture treatment: history and current state. Journal of Chinese Integrative Medicine. 2004;2(4):306–313. doi: 10.3736/jcim20040424.
    1. Zhao Y. Y., Li W. Y. Effects of moxa smoke on moxibustion doctors suffering from chronic pharyngolaryngitis. Lishizhen Medicine and Materia Medica Research. 1801;24(7):1801–1802.
    1. Mo F., Chi C., Guo M., Chu X., Li Y., Shen X. Characteristics of selected indoor air pollutants from moxibustion. Journal of Hazardous Materials. 2014;270:53–60. doi: 10.1016/j.jhazmat.2014.01.042.
    1. Li C. M. The influence of inhalation of moxa smoke on moxibustion doctors. Journal of Traditional Chinese Medicine. 1994;16:57–58.
    1. Xu J., Deng H., Shen X. Safety of moxibustion: a systematic review of case reports. Evidence-Based Complementary and Alternative Medicine. 2014;2014:10. doi: 10.1155/2014/783704.783704
    1. Hsu Y., Chao H., Shih S. Human exposure to airborne aldehydes in Chinese medicine clinics during moxibustion therapy and its impact on risks to health. Journal of Environmental Science and Health, Part A: Toxic/Hazardous Substances and Environmental Engineering. 2015;50(3):260–271. doi: 10.1080/10934529.2015.981112.
    1. MacPherson H., Altman D. G., Hammerschlag R., et al. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. Journal of Evidence-Based Medicine. 2010;3(3):140–155. doi: 10.1111/j.1756-5391.2010.01086.x.
    1. Scharf H. P., Mansmann U., Streitberger K., et al. Acupuncture and knee osteoarthritis: a three-armed randomized trial. Annals of Internal Medicine. 2006;145(1):12–20. doi: 10.7326/0003-4819-145-1-200607040-00005.
    1. Bellamy N., Buchanan W. W., Goldsmith C. H., Campbell J., Stitt L. W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. The Journal of Rheumatology. 1988;15(12):1833–1840.
    1. Kim T.-H., Kim K. H., Kang J. W., et al. Moxibustion treatment for knee osteoarthritis: a multi-centre, non-blinded, randomised controlled trial on the effectiveness and safety of the moxibustion treatment versus usual care in knee osteoarthritis patients. PLoS ONE. 2014;9(7) doi: 10.1371/journal.pone.0101973.e101973
    1. Kwon O. S., Cho S. J., Choi K.-H., et al. Safety recommendations for moxa use based on the concentration of noxious substances produced during commercial indirect moxibustion. Acupuncture in Medicine. 2017;35(2):93–99. doi: 10.1136/acupmed-2016-011105.
    1. Bell M. L., Dominici F., Ebisu K., Zeger S. L., Samet J. M. Spatial and temporal variation in PM(2.5) chemical composition in the united states for health effects studies. Environmental Health Perspectives. 2007;115(7):989–995. doi: 10.1289/ehp.9621.
    1. Park J.-E., Lee S.-S., Lee M. S., Choi S.-M., Ernst E. Adverse events of moxibustion: a systematic review. Complementary Therapies in Medicine. 2010;18(5):215–223. doi: 10.1016/j.ctim.2010.07.001.
    1. Chen R., Chen M., Su T., et al. Heat-sensitive moxibustion in patients with osteoarthritis of the knee: a three-armed multicentre randomised active control trial. Acupuncture in Medicine. 2015;33(4):262–269. doi: 10.1136/acupmed-2014-010740.
    1. White A., Hayhoe S., Hart A., Ernst E. Survey of adverse events following acupuncture (SAFA): A prospective study of 32,000 consultations. Acupuncture in Medicine. 2001;19(2):84–92. doi: 10.1136/aim.19.2.84.
    1. Melchart D., Weidenhammer W., Streng A., et al. Prospective investigation of adverse effects of acupuncture in 97 733 patients. JAMA Internal Medicine. 2004;164(1):104–105. doi: 10.1001/archinte.164.1.104.
    1. Yamashita H., Tsukayama H., Hori N., Kimura T., Tanno Y. Incidence of adverse reactions associated with acupuncture. The Journal of Alternative and Complementary Medicine. 2000;6(4):345–350. doi: 10.1089/10755530050120718.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi